According to the studies, the main signal pathways activated by ALK kinase were RAS/MAPK, PI3K/AKT, and JAK/STAT, among which crizotinib can inhibit the phosphorylation of ERK and AKT in NCI-H3122 cells and tumor growth in xenograft tumor models [45]. This evidence concerns the gene AKT1 and neoplasm.